Difference between revisions of "The Compendium of Cancer Genome Aberrations"
Jump to navigation
Jump to search
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) |
Bailey.Glen (talk | contribs) |
||
| (12 intermediate revisions by 2 users not shown) | |||
| Line 13: | Line 13: | ||
<br> | <br> | ||
<br> | <br> | ||
| + | |||
*Join the CCGA community! If you would like to contribute as an '''<u>[[Description of CCGA Roles|Author or Other Role]]</u>''', please complete a few brief questions on our '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''. We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. [[Volunteer Assignments and Opportunities|'''<u>Please join the effort by looking through the authorship opportunities</u>''']]! | *Join the CCGA community! If you would like to contribute as an '''<u>[[Description of CCGA Roles|Author or Other Role]]</u>''', please complete a few brief questions on our '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''. We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. [[Volunteer Assignments and Opportunities|'''<u>Please join the effort by looking through the authorship opportunities</u>''']]! | ||
| Line 19: | Line 20: | ||
*Meet our '''<u>[[Leadership|Editorial Leadership]]</u>''', '''<u>[[CCGA Workgroup|CCGA Workgroup Members]]</u>''' and [[Communications Liaison|<u>'''Communications Liaison'''</u>]]. | *Meet our '''<u>[[Leadership|Editorial Leadership]]</u>''', '''<u>[[CCGA Workgroup|CCGA Workgroup Members]]</u>''' and [[Communications Liaison|<u>'''Communications Liaison'''</u>]]. | ||
| − | *For contributors, we've created a '''<u>[[ | + | *For contributors, we've created a '''<u>[[Video Tutorials]]</u>''' demonstrating how to add content to the CCGA. Please also refer to helpful '''<u>[[Author Instructions|Author Instructions]]</u>'''. |
*Become a part of our Twitter family for the latest updates [https://twitter.com/ccgawiki '''@ccgawiki''']. | *Become a part of our Twitter family for the latest updates [https://twitter.com/ccgawiki '''@ccgawiki''']. | ||
| Line 25: | Line 26: | ||
[[File:CGC logo only.png|100px|link=Main_Page]]<span id="fp-span-cgc-pre"> '''CGC Workgroups Recurrent Loci Tables'''</span><span id="fp-span-cgc" style="display: block; margin-top: -62px; margin-left: 385px;"> [[AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|AML]] | [[MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray|MDS/MPN]] | [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH|CLL]] | [[Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray|CNS Tumors]] | [[Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations|Plasma Cell Neoplasms]] | [[Breast Cancer Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|Breast Cancer]] | [[Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations|Renal Neoplasia]] | [[B-ALL Tables: Prognostic Genomic Abnormalities and Recurrent Gene Fusions|B-ALL]]</span> | [[File:CGC logo only.png|100px|link=Main_Page]]<span id="fp-span-cgc-pre"> '''CGC Workgroups Recurrent Loci Tables'''</span><span id="fp-span-cgc" style="display: block; margin-top: -62px; margin-left: 385px;"> [[AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|AML]] | [[MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray|MDS/MPN]] | [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH|CLL]] | [[Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray|CNS Tumors]] | [[Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations|Plasma Cell Neoplasms]] | [[Breast Cancer Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|Breast Cancer]] | [[Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations|Renal Neoplasia]] | [[B-ALL Tables: Prognostic Genomic Abnormalities and Recurrent Gene Fusions|B-ALL]]</span> | ||
| + | <br> | ||
<br> | <br> | ||
<br> | <br> | ||
| Line 30: | Line 32: | ||
<div style="height:150px;"> | <div style="height:150px;"> | ||
<div class="bottom-fp-links-column" style="width: 24%; float: left;"> | <div class="bottom-fp-links-column" style="width: 24%; float: left;"> | ||
| − | <div style="float: left; padding-right: | + | <div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;................"> |
| − | [[File:Plus2.png|30px|link= | + | [[File:Plus2.png|30px|link=[[Video Tutorials]]]] |
</div> | </div> | ||
<div> | <div> | ||
| − | <h4>[[ | + | <h4>[[Video Tutorials]]</h4> |
| − | |||
| − | |||
| − | |||
</div> | </div> | ||
</div> | </div> | ||
<div class="bottom-fp-links-column" style="width: 24%; float: left;"> | <div class="bottom-fp-links-column" style="width: 24%; float: left;"> | ||
<div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;"> | <div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;"> | ||
| − | [[File:Arrow.png|30px|link= | + | [[File:Arrow.png|30px|link=[[Join Us!]]]] |
</div> | </div> | ||
<div> | <div> | ||
<h4>[[Join Us!]]</h4> | <h4>[[Join Us!]]</h4> | ||
| − | |||
</div> | </div> | ||
</div> | </div> | ||
<div class="bottom-fp-links-column" style="width: 24%; float: left;"> | <div class="bottom-fp-links-column" style="width: 24%; float: left;"> | ||
| − | <div style="float: left; padding-left: 10px; padding-right: | + | <div style="float: left; padding-left: 10px; padding-right: 15px; height: 150px;"> |
| − | [[File:Ask.png|30px|link= | + | [[File:Ask.png|30px|link=[[Frequently Asked Questions (FAQs)]]]] |
</div> | </div> | ||
<div> | <div> | ||
| − | <h4> | + | <h4>[[Frequently Asked Questions (FAQs)|Frequently Asked Questions (FAQs)]]</h4> |
| − | |||
</div> | </div> | ||
Latest revision as of 12:39, 19 September 2024
Search content structured based on the WHO Classification (click book image). Reference: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022. The hierarchical tumour classification structure is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.
Welcome to the Compendium of Cancer Genome Aberrations (CCGA)! The CCGA is a collaborative effort to document and describe clinically relevant chromosomal and other genomic abnormalities in cancer structured based on current WHO classification as published by IARC. The Wiki style interface allows for real-time editing and content sharing within our genetics community. This resource is sponsored and supported by the Cancer Genomics Consortium (CGC) and contributed to by colleagues with an interest in clinical cytogenetics, molecular genetics and genomics in cancer.
- Join the CCGA community! If you would like to contribute as an Author or Other Role, please complete a few brief questions on our Volunteer Form. We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. Please join the effort by looking through the authorship opportunities!
- Contact us for more information or suggestions for updates.
- Meet our Editorial Leadership, CCGA Workgroup Members and Communications Liaison.
- For contributors, we've created a Video Tutorials demonstrating how to add content to the CCGA. Please also refer to helpful Author Instructions.
- Become a part of our Twitter family for the latest updates @ccgawiki.
CGC Workgroups Recurrent Loci Tables AML | MDS/MPN | CLL | CNS Tumors | Plasma Cell Neoplasms | Breast Cancer | Renal Neoplasia | B-ALL
